Nasopharyngeal cancer-derived microRNA-21 promotes immune suppressive B cells

Cellular and Molecular Immunology

Volumn 12, Issue 6, 2015, Pages 750-756

  Miao, Bei Ping ^a   Zhang, Rui Shi ^a   Li, Meng ^b   Fu, Yun Ting ^b,c,d   Zhao, Miao ^b,c,d   Liu, Zhi Gang ^b   Yang, Ping Chang ^b,d  

^a THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

^b SHENZHEN UNIVERSITY   (China)

^c Shenzhen Institute of Otorhinolaryngology   (China)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

B lymphocyte; immune regulation; interleukin 10; microRNA; nasopharyngeal cancer

Indexed keywords

INTERLEUKIN 10; MICRORNA 21; NUCLEAR FACTOR I; NUCLEAR FACTOR I A; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; IL10 PROTEIN, HUMAN; MICRORNA; MIRN21 MICRORNA, HUMAN; NFIA PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; CANCER CELL LINE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; NASOPHARYNX CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; AGONISTS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; NASOPHARYNX TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-10; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; NFI TRANSCRIPTION FACTORS; POLY I-C; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 84946089237     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/cmi.2014.129     Document Type: Article

References (32)

1. Zhang L, Chen QY, Liu H, Tang LQ, Mai HQ. Emerging treatment options for nasopharyngeal carcinoma. Drug Des Devel Ther 2013; 7: 37-52.
2. Pan CC, Lu J, Yu JR, Chen P, Li W, Huang ZL, et al. Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: a study of 1027 cases and review of the literature. Exp Ther Med 2012; 4: 334-338.
3. Alon EE, Lipschitz N, Bedrin L, Gluck I, Talmi Y, Wolf M, et al. Delayed sino-nasal complications of radiotherapy for nasopharyngeal carcinoma. Otolaryngol Head Neck Surg 2014; 151: 354-358.
4. Nishikawa H, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Curr Opin Immunol 2014; 27: 1-7.
5. Mahalingam J, Lin CY, Chiang JM, Su PJ, Chu YY, Lai HY, et al. CD41 T cells expressing latency-Associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer. PLoS One 2014; 9: e108554.
6. Chung AY, Li Q, Blair SJ, de Jesus M, Dennis KL, LeVea C, et al. Oral interleukin-10 alleviates polyposis via neutralization of pathogenic Tregulatory cells. Cancer Res 2014; 74: 5377-5385.
7. Wang BQ, Zhang CM, Gao W, Wang XF, Zhang HL, Yang PC. Cancerderived matrix metalloproteinase-9 contributes to tumor tolerance. J Cancer Res Clin Oncol 2011; 137: 1525-1533.
8. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
9. Vincent K, Pichler M, Lee GW, Ling H. MicroRNAs, genomic instability and cancer. Int J Mol Sci 2014; 15: 14475-14491.
10. Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol 2014; 20: 10432-10439.
11. Li Y, Yan L, Zhang W, Wang H, Chen W, Hu N, et al. miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression. Int J Clin Exp Pathol 2014; 7: 3478-3487.
12. Sekar D, Hairul Islam VI, Thirugnanasambantham K, Saravanan S. Relevance of miR-21 in HIV and non-HIV-related lymphomas. Tumour Biol 2014; 35: 8387-8393.
13. Wang L, He L, Zhang R, Liu X, Ren Y, Liu Z, et al. Regulation of T lymphocyte activation by microRNA-21. Mol Immunol 2014; 59: 163-171.
14. Liu T, He SH, Zheng PY, Zhang TY, Wang BQ, Yang PC. Staphylococcal enterotoxin B increases TIM4 expression in human dendritic cells that drives naive CD4 T cells to differentiate into Th2 cells. Mol Immunol 2007; 44: 3580-3587.
15. Zhang HP, Wu Y, Liu J, Jiang J, Geng XR, Yang G, et al. TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation. Sci Rep 2013; 3: 3345.
16. Berin MC, Yang PC, Ciok L, Waserman S, Perdue MH. Role for IL-4 in macromolecular transport across human intestinal epithelium. Am J Physiol 1999; 276: C1046-C1052.
17. Wang M, Gu H, Wang S, Qian H, Zhu W, Zhang L, et al. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol Med Rep 2012; 5: 1514-20.
18. Schmittgen TD, Livak KJ. Analyzing real-Time PCR data by the comparative CT method. Nat Protoc 2008; 3: 1101-1108.
19. Geng XR, Yang G, Li M, Song JP, Liu ZQ, Qiu S, et al. Insulin-like growth factor-2 enhances functions of antigen (Ag)-specific regulatory B cells. J Biol Chem 2014; 289: 17941-17950.
20. Czarneski J, Lin YC, Chong S, McCarthy B, Fernandes H, Parker G, et al. Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma. Leukemia 2004; 18: 597-606.
21. Liu X, Luo HN, Tian WD, Lu J, Li G, Wang L, et al. Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol Ther 2013; 14: 1133-1142.
22. Quinn SR, ONeill LA. The role of microRNAs in the control and mechanism of action of IL-10. Curr Top Microbiol Immunol 2014; 380: 145-155.
23. Zhang Y, Sun R, Liu B, Deng M, Zhang W, Li Y, et al. TLR3 activation inhibits nasopharyngeal carcinoma metastasis via downregulation of chemokine receptor CXCR4. Cancer Biol Ther 2009; 8: 1826-1830.
24. McClure C, Brudecki L, Ferguson DA, Yao ZQ, Moorman JP, McCall CE, et al. MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis. Infect Immun 2014; 82: 3816-3825.
25. Jin G, Hamaguchi Y, Matsushita T, Hasegawa M, Le Huu D, Ishiura N, et al. B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B cells. J Allergy Clin Immunol 2013; 131: 1674-1682.
26. Karray H, Ayadi W, Fki L, Hammami A, Daoud J, Drira MM, et al. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J Med Virol 2005; 75: 593-602.
27. Yang CF, Peng LX, Huang TJ, Yang GD, Chu QQ, Liang YY, et al. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway. Cancer Lett 2014; 344: 260-271.
28. He JF, Jia WH, Fan Q, Zhou XX, Qin HD, Shugart YY, et al. Genetic polymorphisms of TLR3 are associated with nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 2007; 7: 194.
29. Yang GD, Huang TJ, Peng LX, Yang CF, Liu RY, Huang HB, et al. Epstein-Barr virus-encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L. PLoS One 2013; 8: e78355.
30. Wisniewski J, Agrawal R, Woodfolk JA. Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts. Clin Exp Allergy 2013; 43: 164-176.
31. Mauri C, Ehrenstein MR. The shorthistory of regulatory B cells. Trends Immunol 2008; 29: 34-40.
32. Hu H, Jiang W, Xi X, Zou C, Ye Z. MicroRNA-21 Attenuates renal ischemia reperfusion injury via targeting caspase signaling in mice. Am J Nephrol 2014; 40: 215-223.